NCT06469385View on ClinicalTrials.gov

Topical ENS-002 for Atopic Dermatitis in Adults

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

August 4, 2025

Study Completion Date

August 4, 2025

Conditions
Atopic DermatitisAtopic Dermatitis Eczema
Interventions
BIOLOGICAL

ENS-002

"Live biotherapeutic product (LBP) consisting of commensal, clonal, non-pathogenic bacteria.~Low Dose ENS-002 High Dose ENS-002"

Trial Locations (3)

33024

Encore Medical Research, Hollywood

78759

Derm Research, Austin

01915

Northeast Dermatology Associates, Beverly

Sponsors
All Listed Sponsors
lead

Concerto Biosciences

INDUSTRY

NCT06469385 - Topical ENS-002 for Atopic Dermatitis in Adults | Biotech Hunter | Biotech Hunter